# FDA Inspection 1001178 - Biomat USA Inc - January 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8bd69529-c173-4523-bd83-b1ff714a37c2
Source feed: FDA_Inspections

> FDA Inspection 1001178 for Biomat USA Inc on January 17, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001178
- Company Name: Biomat USA Inc
- Inspection Date: 2017-01-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1117469 - 2020-01-31](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/07f7f776-1b89-4852-9b97-062ac926e24a)
- [FDA Inspection 889234 - 2014-07-31](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d0d417e3-592c-4c66-911f-809f4398eb44)
- [FDA Inspection 738928 - 2011-08-11](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4ce24775-2989-4663-957c-3ce658c41425)
- [FDA Inspection 569077 - 2009-03-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4ce1d1c9-b281-498f-9bc9-2aeb09719695)

Company: https://www.keypedia.com/companies/biomat-usa-inc/b16b4735-0b48-4d74-87cf-24fc2de7bab6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d